ERBB2 and invasive breast carcinoma: ACC in breast tissues constitutes ~1% of all invasive breast cancers and is categorized as triple-negative for estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2).